Browsing by Author "Cordero Rigol, José Antonio"

Now showing items 1-6 of 6

    • An automated classification pipeline for tables in pharmacokinetic literature 

      Smith, Victoria; Gonzalez Hernandez, Ferran; Wattanakul, Thanaporn; Chotsiri, Palang; Cordero Rigol, José Antonio; Ballester, Maria Rosa; Duran, Màrius; Fanlo Escudero, Olga; Lilaonitkul, Watjana; Standing, Joseph F.; Kloprogge, Frank (Scientific reports, 2025, 15: 10071, 2025-03)
      Pharmacokinetic (PK) models are essential for optimising drug candidate selection and dosing regimens in drug development. Preclinical and population PK models benefit from integrating prior knowledge ...

    • Anti‐vascular endothelial growth factor for proliferative diabetic retinopathy 

      Martínez Zapata, Mª José; Salvador, Ignacio; Martí Carvajal, Arturo José; Pijoán, José I.; Cordero Rigol, José Antonio; Ponomarev, Dmitry; Kernohan, Ashleigh; Solà, Ivan; Virgili, Gianni (Cochrane Database of Systematic Reviews, 2023, núm. 3, Art. No.: CD008721, 2023-03)
      BackgroundProliferative diabetic retinopathy (PDR) is an advanced complication of diabetic retinopathy that can cause blindness. It consists of thepresence of new vessels in the retina and vitreous ...

    • Anti‐vascular endothelial growth factor for proliferative diabetic retinopathy 

      Martínez Zapata, Mª José; Martí Carvajal, Arturo José; Solà, Ivan; Pijoán, José I.; Buil Calvo, José Antonio; Cordero Rigol, José Antonio; Evans, Jennifer R. (Cochrane Database of Systematic Reviews, 2014, núm. 11, Art. No.: CD008721, 2014-11)
      Background: Proliferative diabetic retinopathy (PDR) is a complication of diabetic retinopathy that can cause blindness. Although panretinal photocoagulation (PRP) is the treatment of choice for PDR, ...

    • Intermittent androgen deprivation therapy: recommendations to improve the management of patients with prostate cancer following the GRADE approach 

      Bonfill, X. (Xavier); Arévalo Rodríguez, Ingrid; Martínez García, Laura; Quintana Ruiz, M. Jesús; Buitrago, Diana; Lobos Urbina, Diego; Cordero Rigol, José Antonio (Cancer Management and Research, 2018, vol. 10, p. 2357–2367, 2018-08)
      Purpose: The purpose of this study was to provide evidence-based recommendations of intermittent androgen deprivation therapy (IADT) compared with continuous androgen deprivation therapy (CADT) for men ...

    • Named entity recognition of pharmacokinetic parameters in the scientific literature 

      Gonzalez Hernandez, Ferran; Nguyen, Quang; Smith, Victoria; Cordero Rigol, José Antonio; Ballester, Maria Rosa; Duran, Màrius; Solé, Albert; Chotsiri, Palang; Wattanakul, Thanaporn; Mundin, Gill; Lilaonitkul, Watjana; Standing, Joseph F.; Kloprogge, Frank (Scientific reports, 2024, 14, 23485, 2024-10)
      The development of accurate predictions for a new drug’s absorption, distribution, metabolism, and excretion profiles in the early stages of drug development is crucial due to high candidate failure ...

    • Prevalence study of intermittent hormonal therapy of prostate cancer patients in Spain [version 2; peer review: 2 approved] 

      Bonfill, X. (Xavier); Auladell-Rispau, Ariadna; Gich Saladich, Ignasi; Zamora, Javier; Saiz, Luis Carlos; Pijoán, José I.; Urreta-Barallobre, Iratxe; Cordero Rigol, José Antonio (F1000Research, 2022, 10:1069, 2023-11)
      Background: Although intermittent androgen deprivation therapy was introduced many years ago to improve patients’ quality of life with the same carcinologic efficiency as continuous hormonal therapy, ...